默瑞生物是美國(guó)MTI-globalstem總代理-73771/現(xiàn)貨

　默瑞生物是美國(guó)MTI-globalstem公司的中國(guó)授權(quán)總代理商，歡迎大家咨詢(xún)訂貨。

　　默瑞熱線(xiàn)：4006-400-850

　　售前咨詢(xún)：info@moreybio.com

　　產(chǎn)品訂購(gòu)：order@moreybio.com

　　售后支持：tech@moreybio.com

　　默瑞官網(wǎng)：www.moreybio.com

　　產(chǎn)品介紹

　　產(chǎn)品名稱(chēng)：DNA-In® A549 1.0 ml

　　產(chǎn)品描述：

　　DNA-In® A549 Transfection Reagent

　　A Transfection Reagent for A549 Cells

　　DNA-In® Cell-Specific Transfection Reagents are a line of transfection products developed by the lead members of the scientific team that invented the Lipofectamine® and Lipofectamine® 2000. These cell-specific reagents offer maximum DNA delivery in targeted common cell lines.

　　Features

　　Optimized for maximum transfection efficiency and cell viability in A549 cells.

　　One-step process: simply add DNA-In® A549 Transfection Reagent to diluted DNA, incubate 10 minutes, and add to pre-plated cells

　　Minimal toxicity - no need to replace medium after transfection

　　Maximum Transfection Efficiency in A549

　　Above, A549 cells were plated at 70% confluency and were transfected with the EF-1 alpha promoter-GFP 24 hours after plating. DNA-In® A549 transfected cells (left image) show significantly higher expression vs LF3K transfected cells (right image).

　　Superior Transfection Efficiency and Maximum Cell Viability

　　During its development and validation process, DNA-In® A549 Transfection Reagent underwent extensive testing in many primary and cultured cells. In a head-to-head comparison study, DNA-In A549 Reagent consistently outperformed Lipofectamine® 2000 and Lipofectamine® 3000 transfection reagents.

　　The following charts show side-by-side comparisons of DNA-In® A549, Lipofectamine® 2000 (LF2K) and Lipofectamine® 3000 (LFK) in A549 cells:

　　公司介紹

　　mti-globalstem，是生命科學(xué)領(lǐng)域前沿工具和試劑的供應(yīng)商。mti-globalstem提供優(yōu)勢(shì)產(chǎn)品在轉(zhuǎn)染試劑、神經(jīng)科學(xué)、干細(xì)胞生物學(xué)。他們填補(bǔ)了原代和ipsc獲得神經(jīng)細(xì)胞、干細(xì)胞和飼養(yǎng)層細(xì)胞的空白，優(yōu)化了生長(zhǎng)培養(yǎng)基和補(bǔ)充物質(zhì)，提供了一個(gè)貴族試劑的創(chuàng)新平臺(tái)——最大效率的遞送核酸到干細(xì)胞和神經(jīng)細(xì)胞。

　　MTI-GlobalStem公司成立于2006年，最初名為GlobalStem，在2010年被Molecular Transfer公司(MTI)收購(gòu)，總部位于美國(guó)馬里蘭州蓋瑟斯堡，致力于開(kāi)發(fā)和推廣細(xì)胞轉(zhuǎn)染、神經(jīng)生物學(xué)以及干細(xì)胞研究所用的工具和試劑。此外，這家公司還提供干細(xì)胞、分化神經(jīng)元和大規(guī)模的細(xì)胞培養(yǎng)制造服務(wù)。

　　默瑞生物是美國(guó)MTI-globalstem公司, 73771-mRNA-In™1.0 ml/現(xiàn)貨/代理商